Cipla (CIPLA) Weekly Analysis
Price & Volume
The stock price experienced a minor decline of 0.25% during the week. Trading activity slowed significantly, with total volume dropping by over 50% compared to the previous week. The stock is currently trading near its 200-day moving average, which is the average closing price over the last 200 days.
Technicals
The stock closed at 1397.5 this week, reflecting a 0.25% decrease. The Relative Strength Index (RSI), which measures the speed and change of price movements, sits at 57.65, indicating moderate momentum. The Moving Average Convergence Divergence (MACD), a tool used to identify trend direction and momentum, shows the MACD line below the signal line, suggesting a shift in momentum. Bollinger Band width, representing market volatility or the range of price movement, is at 11.37%. The price remains below the 50-week moving average, which acts as a long-term trend indicator, while the 20-week moving average remains flat.
Fundamentals
In the recent quarter ending March 2026, Cipla experienced a revenue decline of 2.8% year-over-year (YoY) and a significant 7.5% quarter-over-quarter (QoQ). Net profit also saw a sharp YoY decrease of 55.3% and a 19.4% QoQ drop. The company's operating margin for the quarter was 15.0%. The trailing twelve months (TTM) data is not available to assess longer-term annual trends. The current valuation stands at 32.9x Price-to-Earnings (PE) and 3.3x Price-to-Book (PB).
News
During the week ending June 5, 2026, Cipla remained a focus for investors regarding corporate actions and broader market sentiment. On June 4, 2026, the company was identified as one of the stocks for which investors needed to complete purchases to qualify for upcoming dividend payouts. Simultaneously, Cipla faced downward revisions in Nifty 50 earnings per share estimates during May 2026. Despite these specific adjustments, the pharmaceutical sector continued to receive positive attention from market analysts, who highlighted the industry as a resilient area for long-term investment. These developments underscored a period of mixed sentiment for the company, balancing immediate shareholder benefits against broader earnings growth concerns within the current market environment.
Events
Cipla Limited has allotted 44,770 equity shares of ₹2 each to employees following the exercise of stock options and appreciation rights. This allotment increases the company's total paid-up share capital to ₹1,61,56,90,632.
Cipla Limited has announced its 90th Annual General Meeting (AGM) scheduled for June 25, 2026, to be conducted via video conferencing. Shareholders are provided with e-voting facilities to cast their votes on proposed resolutions, with the notice and annual report already disseminated electronically.
Cipla Limited has announced that it will participate in an investor conference hosted by ICICI Securities in Mumbai on June 9, 2026.
Cipla Limited has released its Business Responsibility and Sustainability Report for the financial year 2025-26, fulfilling regulatory disclosure requirements under SEBI guidelines. The report provides stakeholders with information regarding the company's environmental, social, and governance performance.
Cipla Limited has scheduled its 90th Annual General Meeting for 25th June 2026 via video conferencing, where shareholders will consider the adoption of financial statements and a recommended final dividend of ₹13 per equity share.
Cipla reported its highest-ever annual revenue of ₹28,163 crore for FY26, despite a decline in annual EBITDA to ₹5,925 crore and PAT to ₹3,879 crore. The company maintained a strong net-cash position, supporting its ongoing growth investments across key business segments.
Cipla Limited reported strong FY26 results, with its India business surpassing ₹12,500 crores in revenue and global operations achieving significant milestones in respiratory and complex generics. The company's growth was driven by robust performance across its domestic franchise, strategic product launches, and successful regulatory clearances at key manufacturing facilities.
Cipla Limited has announced its 90th Annual General Meeting (AGM) scheduled for June 25, 2026, to be conducted via video conferencing. Shareholders are provided with e-voting facilities to cast their votes on proposed resolutions, with the notice and annual report already disseminated electronically.
Cipla Limited has announced that it will participate in an investor conference hosted by ICICI Securities in Mumbai on June 9, 2026.
Cipla Limited has released its Business Responsibility and Sustainability Report for the financial year 2025-26, fulfilling regulatory disclosure requirements under SEBI guidelines. The report provides stakeholders with information regarding the company's environmental, social, and governance performance.
Cipla Limited has scheduled its 90th Annual General Meeting for 25th June 2026 via video conferencing, where shareholders will consider the adoption of financial statements and a recommended final dividend of ₹13 per equity share.
Cipla reported its highest-ever annual revenue of ₹28,163 crore for FY26, despite a decline in annual EBITDA to ₹5,925 crore and PAT to ₹3,879 crore. The company maintained a strong net-cash position, supporting its ongoing growth investments across key business segments.
Cipla Limited reported strong FY26 results, with its India business surpassing ₹12,500 crores in revenue and global operations achieving significant milestones in respiratory and complex generics. The company's growth was driven by robust performance across its domestic franchise, strategic product launches, and successful regulatory clearances at key manufacturing facilities.
Weekly Snapshot
Highlights
- The stock price declined by 0.25% this week as trading volume dropped by 53.86% compared to the previous week.
- Cipla was identified as a top Nifty 50 constituent for earnings per share downgrades during May 2026, impacting market sentiment.
- The company announced its 90th Annual General Meeting scheduled for June 25, 2026, with a recommended final dividend of ₹13 per equity share.
- Technical indicators show the stock trading at its 200-day moving average, reflecting a range-bound regime with mixed momentum signals.
- Cipla filed its Business Responsibility and Sustainability Report for FY 2025-26, confirming Achin Gupta as MD & GCEO effective April 1, 2026.
What This Means
Cipla is currently navigating a period of consolidation, evidenced by the stock price hovering at its 200-day moving average and a significant reduction in weekly trading volume. While the company maintains a stable long-term technical position, recent market sentiment has been tempered by earnings per share downgrades within the Nifty 50 index. Investors are currently focused on upcoming corporate actions, specifically the dividend payout and the 90th Annual General Meeting, which provide a degree of stability amidst broader earnings growth concerns.
Latest Quarter Info
For the period ending March 2026, the company reported revenue of 6541.0. While the operating margin remained stable at 15.0%, both revenue and net profit experienced declines compared to the previous quarter and the same quarter last year. Specifically, revenue saw a QoQ decrease of 7.5% and a YoY decrease of 2.8%. Net profit showed a more significant downturn, with a QoQ drop of 19.4% and a substantial YoY decrease of 55.3%. This trend is also reflected in the Earnings Per Share (EPS), which decreased by 17.9% QoQ and 54.6% YoY. The mixed signals from revenue momentum and profitability trends warrant close observation.